Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/29/2005US20050287540 Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
12/29/2005US20050287539 Methods and compositions for preparing capped RNA
12/29/2005US20050287537 Amino acid modification; improved thermostability, altered substrate specificity, ph optimum and cleavage pattern; economical and efficient
12/29/2005US20050287530 TCL-1b gene and protein and related methods and compositions
12/29/2005US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
12/29/2005US20050287526 Nucleic acid amplification method
12/29/2005US20050287525 bioassay for testing peptides that bind to domain peptides of human immunodeficiency virus type I (HIV-1); peptides used for treating viral diseases
12/29/2005US20050287521 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof
12/29/2005US20050287171 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition
12/29/2005US20050287169 Methods of use of genes of pyridoxal 5'-phosphate biosynthesis in Bacillus subtilis: avirulent strains for vaccines, and methods for identification of antibacterial agents
12/29/2005US20050287168 Recombinant spores
12/29/2005US20050287166 Malarial pre-erythrocytic stage polypeptide molecules
12/29/2005US20050287165 Meningococcal antigens
12/29/2005US20050287164 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/29/2005US20050287162 Recombinant fowlpox virus
12/29/2005US20050287160 Useful for treatment and prevention of prostate cancer, especially when associated with bone metastases; also a cytotoxic T lymphocyte that specifically recognizes complex of HLA-A24 antigen and the cancer antigen peptide
12/29/2005US20050287151 Secreted protein therapeutics and uses thereof
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005US20050287141 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2005US20050287129 Vectors and methods for long-term immune evasion to prolong transplant viability
12/29/2005US20050287128 RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
12/29/2005US20050287123 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
12/29/2005US20050287122 Adeno-associated virus vectors with modified capsid proteins for use as gene transfer and proliferation tools; gene therapy; genetic vaccines
12/29/2005US20050287120 Cancer - targeted viral vectors
12/29/2005US20050287119 Treating a superficial interferon-resistant tumor of the bladder by contacting the tumor with Syn 3 and a replication-deficient adenoviral recombinant vector encoding an interferon alpha, where the vector and Syn3 are instilled intravesically; interferon alpha 2b,2a,2 or 1
12/29/2005US20050287116 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene
12/29/2005US20050287110 Cationic graft-compolymer for non-viral gene delivery vector
12/29/2005DE19928073B4 Transkonjugationsplasmid für die Mutagenese von Pasteurellaceae Transkonjugationsplasmid for mutagenesis of Pasteurellaceae
12/29/2005DE102004028267A1 Sorptionsmittel für Nukleinsäuren, enthaltend säureaktiviertes Schichtsilicat Sorbents for nucleic acids containing acid-activated layer
12/29/2005DE102004026744A1 Erfindung betreffend cDNA-Herstellung aus Zellen nach Laser-Mikrodissektion Invention relating cDNA preparation from cells by laser capture microdissection
12/29/2005DE102004026309A1 Pharamzeutische Zusammensetzung zur Behandlung allergischer Erkrankungen, pathologischer Atemswegsveränderungen und von Krebs durch Modulation der Genexpression des Stat6 Pharamzeutische composition for the treatment of allergic diseases, pathological airway changes and cancer through modulation of gene expression of Stat6
12/29/2005DE102004022574A1 Pharmaceutical formulation, for use in inflammatory disorders, identifies the rabies virus protein P as an interferon antagonist with substitution of the P-coded nucleic acid sequence
12/29/2005DE10061634B4 Verfahren zur Bestimmung unbekannter DNS-Sequenzen in komplexen Genomen Process for the determination of unknown DNA sequences in complex genomes
12/29/2005CA2735315A1 Plastid transit peptides
12/29/2005CA2734716A1 Plastid transit peptides
12/29/2005CA2734624A1 Plastid transit peptides
12/29/2005CA2734561A1 Plastid transit peptides
12/29/2005CA2591858A1 Proteases derived from norcardiopsis
12/29/2005CA2571078A1 Reduced susceptibility towards pathogens, in particular oomycetes, such as downy mildew in lettuce and spinach
12/29/2005CA2570512A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxydase in the seeds
12/29/2005CA2570510A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same
12/29/2005CA2570508A1 Preparation of protective antigen from bacillus anthracis
12/29/2005CA2570171A1 Methods of making nanotechnological and macromolecular biomimetic structures
12/29/2005CA2570034A1 Diagnosis and treatment of siglec-6 associated diseases
12/29/2005CA2570017A1 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
12/29/2005CA2569988A1 Phage microarray profiling of the humoral response to disease
12/29/2005CA2569953A1 Novel maize split-seed explant and methods for in vitro regeneration of maize
12/29/2005CA2569889A1 Plants that produce amylopectin starch with novel properties
12/29/2005CA2569807A1 Oligomeric peptides and their use for the treatment of hiv infections
12/29/2005CA2569304A1 Thymidine kinase
12/29/2005CA2568788A1 Production of polypeptides by improved secretion
12/29/2005CA2568643A1 Treatment of non alcoholic steatotic hepatitis (nash)
12/29/2005CA2568575A1 Analysis of methylated nucleic acid
12/28/2005EP1609867A1 Nucleic acid construct, expression vector and method for enhancing the production of recombinant protein
12/28/2005EP1609866A1 Barley lipoxygenase 1 gene, method of selecting barley variety, material of malt alcoholic drinks and process for producing malt alcoholic drink
12/28/2005EP1609865A2 Hepatitis B virus (HBV) variants
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609862A1 Diabetes-mediating proteins and therapeutic uses thereof
12/28/2005EP1609861A1 Low-molecular weight peptides inhibiting ion channel activity
12/28/2005EP1609859A1 Technique of removing marker gene by transient expression of site-specific recombinase gene
12/28/2005EP1609857A1 Method of demethylating target methylated region of genomic dna
12/28/2005EP1609856A2 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
12/28/2005EP1609855A1 Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein
12/28/2005EP1609853A1 Process for controlling sialylation of proteins produced by mammalian cell culture
12/28/2005EP1609802A1 Transcriptional factor inducing apoptosis in cancer cell
12/28/2005EP1609482A1 Drug for treating hemophilia and method of treating hemophilia using the same
12/28/2005EP1608967A2 Compositions and methods for the diagnosis and treatment of tumor
12/28/2005EP1608786A2 Genomic profiling of regulatory factor binding sites
12/28/2005EP1608785A2 Statistical analysis of regulatory factor binding sites of differentially expressed genes
12/28/2005EP1608780A1 Aptamer selection method
12/28/2005EP1608777A1 Method of inactivating ribonucleases at high temperature
12/28/2005EP1608774A1 Stn gene oligonucleotide primers for detecting salmonella species and detection process using the same
12/28/2005EP1608767A2 Optimized expression of hpv 31 l1 in yeast
12/28/2005EP1608766A2 Glucosidases, nucleic acids encoding them and methods for making and using them
12/28/2005EP1608764A1 A process for the production of l-amino acids using strains of the enterobacteriaceae family which overexpress the galp gene, coding for a galactose proton symporter
12/28/2005EP1608763A2 Compounds and methods to enhance raav transduction
12/28/2005EP1608762A2 Improved alphavirus replicons and helper constructs
12/28/2005EP1608761A2 Mthp promoter element
12/28/2005EP1608760A2 Plants having improved growth characteristics and a method for making the same
12/28/2005EP1608759A2 Enhanced accumulation of carotenoids in plants
12/28/2005EP1608758A1 Plants having modified growth characteristics and method for making the same
12/28/2005EP1608757A1 Modified beta-lactamases and uses thereof
12/28/2005EP1608756A2 Staphylococcus epidermidis antigens
12/28/2005EP1608755A2 Tak1-mediated inhibition of osteogenesis
12/28/2005EP1608754A2 Modulation of cell phenotype by inhibitory rna
12/28/2005EP1608753A1 Antisense oligonucleotides (odn) against smad7 and uses in medical field thereof
12/28/2005EP1608752A2 Method for isolating nucleic acids
12/28/2005EP1608751A2 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity
12/28/2005EP1608750A2 Method and system for rapidly conferring a desired trait to an organism
12/28/2005EP1608749A1 Methods and devices for producing biomolecules
12/28/2005EP1608748A2 Ligational encoding of small molecules
12/28/2005EP1608746A1 Thermally stable amidases
12/28/2005EP1608745A2 FVII OR FVIIa VARIANTS
12/28/2005EP1608744A2 Subtilases
12/28/2005EP1608735A2 Irna conjugates
12/28/2005EP1608733A2 Modified polynucleotides for use in rna interference
12/28/2005EP1608732A2 Compositions and methods of using a synthetic dnase i
12/28/2005EP1608730A2 Truncated baff receptors
12/28/2005EP1608729A2 Rnai arrays and methods for using the same
1 ... 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 ... 4023